AbbVie (NYSE: ABBV) today announced the European Commission (EC) granted marketing authorization for ELAHERE® (mirvetuximab soravtansine) for the treatment of adult patients with folate receptor-alpha ...
Ovarian cancer vaccines are under development, but none are ready for primetime. There are no screening tools for ovarian ...